Malignant Rectal Neoplasm — Trials

Malignant Rectal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,551 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 388
Recruiting: 216
Ph III recruiting: 36
Growth YoY: +12%
Industry share: 5%
Top sponsor: Fudan University
Termination share: 28%
Trials / 1,000 deaths: 30.1 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (153)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07805369	A Phase 1 Study of DEM301 in Participants With Metastatic Colorectal Cancer	not yet recruiting	Phase 1	60	DEM BioPharma, Inc.INDUSTRY	0	Sep 9, 2026	clinicaltrials
NCT07811076	Serine/Glycine-Restricted Diet With Chemoradiotherapy for Rectal Cancer(SG-RCT)	not yet recruiting	Phase 1 / Phase 2	140	Xuelei Ma MDOTHER	1	Sep 9, 2026	clinicaltrials